What is Biosimilar?
A Biosimilar is a type of biologic medication. The term “biosimilar” means that the medication is highly similar to the already approved brand name biologic (“originator” medication)
Please make a donation to the Aplastic Anemia and MDS International Foundation.
Donate Today
A Biosimilar is a type of biologic medication. The term “biosimilar” means that the medication is highly similar to the already approved brand name biologic (“originator” medication)
Pure red cell aplasia (PRCA) is a condition in which the bone marrow stops producing red blood cells that are responsible for carrying oxygen
MarrowForums provides free discussion forums for patients with bone marrow failure diseases
Information about iron levels and the ways they fluctuate during treatment, alongside information about the effects of such fluctuations
A list of organizations & programs that may provide financial resources & other assistance
MDS and AML Research Summaries for Patients from the 2019 American Society of Hematology Annual Meeting
MDS and AML Research Summaries for Patience from the 2018 American Society of Hematology Annual Meeting
Aplastic Anemia and PNH Research Summaries for Patients from the 2018 American Society of Hematology Annual Meeting
Research Summaries for Patients from the 2019 European Hematology Association and the 2019 American Society of Clinical Oncology meetings
Bone Marrow Failure Disease Research Summaries for Patients from the 2020 American Hematology Society Annual Meeting